29 August 2022 - Switzerland becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 booster vaccine.

Moderna today announced that Swissmedic has granted temporary authorisation for the use of Moderna's Omicron targeting bivalent booster vaccine, Spikevax Bivalent Original/Omicron (mRNA-1273.214) for active immunisation to prevent SARS-CoV-2 virus-induced coronavirus-2019 disease for individuals aged 18 years and older.

Read Moderna press release